EP4334338A4 - Conception moléculaire de capteurs de glucose dans des analogues d'insuline sensibles au glucose - Google Patents
Conception moléculaire de capteurs de glucose dans des analogues d'insuline sensibles au glucoseInfo
- Publication number
- EP4334338A4 EP4334338A4 EP22799444.9A EP22799444A EP4334338A4 EP 4334338 A4 EP4334338 A4 EP 4334338A4 EP 22799444 A EP22799444 A EP 22799444A EP 4334338 A4 EP4334338 A4 EP 4334338A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- glucose
- insulin analogues
- molecular design
- sensitive insulin
- sensors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163183325P | 2021-05-03 | 2021-05-03 | |
| PCT/US2022/027504 WO2022235691A1 (fr) | 2021-05-03 | 2022-05-03 | Conception moléculaire de capteurs de glucose dans des analogues d'insuline sensibles au glucose |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP4334338A1 EP4334338A1 (fr) | 2024-03-13 |
| EP4334338A4 true EP4334338A4 (fr) | 2025-06-18 |
Family
ID=83932434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP22799444.9A Withdrawn EP4334338A4 (fr) | 2021-05-03 | 2022-05-03 | Conception moléculaire de capteurs de glucose dans des analogues d'insuline sensibles au glucose |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4334338A4 (fr) |
| CN (1) | CN117337299A (fr) |
| WO (1) | WO2022235691A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3199254A1 (fr) * | 2020-10-22 | 2022-04-28 | The Trustees Of Indiana University | Conceptions moleculaires d'analogues d'insuline sensibles au glucose et clivables par le glucose |
| PE20251287A1 (es) * | 2022-05-18 | 2025-05-14 | Protomer Tech Inc | Compuestos aromaticos que contienen boro y analogos de insulina relacionados |
| CN122055379A (zh) * | 2023-04-11 | 2026-05-15 | 普罗托莫科技公司 | 含有一个或多个二硼酸酯的化合物及相关胰岛素类似物 |
| WO2025096528A1 (fr) * | 2023-10-30 | 2025-05-08 | The Trustees Of Indiana University | Insulines sensibles au glucose à base d'élément de liaison au glucose coopératif |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016149222A2 (fr) * | 2015-03-13 | 2016-09-22 | Case Western Reserve University | Analogues de l'insuline contenant un commutateur de conformation régulé par le glucose |
| WO2017070617A1 (fr) * | 2015-10-21 | 2017-04-27 | Case Western Reserve University | Analogues de l'insuline modifiés avec un diol contenant un commutateur de conformation régulé par le glucose |
| WO2020214955A1 (fr) * | 2019-04-19 | 2020-10-22 | The Trustees Of Indiana University | Stabilisation d'analogues d'insuline prandiale ou basale par un pont diséléniure interne |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12011502708B1 (en) * | 2009-07-06 | 2017-11-10 | Sanofi Aventis Deutschland | Insulin preparations containing methionine |
| MA50552A (fr) * | 2017-11-09 | 2020-09-16 | Novo Nordisk As | Dérivés de liaison à l'albumine sensibles au glucose |
-
2022
- 2022-05-03 EP EP22799444.9A patent/EP4334338A4/fr not_active Withdrawn
- 2022-05-03 CN CN202280032806.1A patent/CN117337299A/zh active Pending
- 2022-05-03 WO PCT/US2022/027504 patent/WO2022235691A1/fr not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016149222A2 (fr) * | 2015-03-13 | 2016-09-22 | Case Western Reserve University | Analogues de l'insuline contenant un commutateur de conformation régulé par le glucose |
| WO2017070617A1 (fr) * | 2015-10-21 | 2017-04-27 | Case Western Reserve University | Analogues de l'insuline modifiés avec un diol contenant un commutateur de conformation régulé par le glucose |
| WO2020214955A1 (fr) * | 2019-04-19 | 2020-10-22 | The Trustees Of Indiana University | Stabilisation d'analogues d'insuline prandiale ou basale par un pont diséléniure interne |
Non-Patent Citations (3)
| Title |
|---|
| JAROSINSKI MARK A ET AL: "'Smart' insulin-delivery technologies and intrinsic glucose-responsive insulin analogues", DIABETOLOGIA, vol. 64, no. 5, 12 March 2021 (2021-03-12), pages 1016 - 1029, XP037394114, ISSN: 0012-186X, DOI: 10.1007/S00125-021-05422-6 * |
| See also references of WO2022235691A1 * |
| WAYNE D. KOHN ET AL: "pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivity", PEPTIDES, vol. 28, no. 4, 1 April 2007 (2007-04-01), pages 935 - 948, XP055017239, ISSN: 0196-9781, DOI: 10.1016/j.peptides.2007.01.012 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022235691A1 (fr) | 2022-11-10 |
| EP4334338A1 (fr) | 2024-03-13 |
| CN117337299A (zh) | 2024-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2308797A3 (fr) | Structure à cavité comportant une interface de collage a base de matériau getter | |
| MX2010001442A (es) | Biosensor interno flexible, dispositivo de insercion de un biosensor interno flexible y metodos relacionados. | |
| AU2016233430B2 (en) | Insulin analogues containing a glucose-regulated conformational switch | |
| PE20191716A1 (es) | Polipeptidos de relaxina modificada que comprenden un mejorador farmacocinetico y sus usos | |
| EP2210600A4 (fr) | Préparation orale à action rapide pouvant augmenter le taux d'arginine dans le sang contenant de la citrulline et de l'arginine | |
| WO2009141171A3 (fr) | Capteur piezo-électrique de mesure de fluctuations de pression | |
| BRPI0408331A (pt) | conjugado de polipetìdeo fisiologicamente ativo possuindo meia vida útil in vivo prolongada | |
| CY1116197T1 (el) | Διαλυμα εγχυσης και ενεσης της λεβεντοπα | |
| FI3474729T3 (fi) | Lääketieteellinen laite sisäänvietävän elementin viemiseksi transkutaanisesti kehon kudokseen | |
| RU2010103450A (ru) | Устройство введения с бистабильными равновесными состояниями | |
| DK1970091T3 (da) | Indføringshoved til medicinske eller farmaceutiske anvendelser | |
| DE602004016687D1 (de) | Dermal befestigte sensorvorrichtung | |
| JP6416540B2 (ja) | ウェアラブル電極 | |
| EP1439842A4 (fr) | Capteurs oxydants destines au traitement du diabete ou a etre utilises dans une transplantation ou a induire une tolerance immunitaire | |
| FR2930447B1 (fr) | Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique | |
| AR107560A1 (es) | Compuesto que disminuye la glucosa en la sangre | |
| Wang et al. | Effect of capillary bridges on the interfacial adhesion of wearable electronics to epidermis | |
| FR2942410B1 (fr) | Vecteur d'injection d'un produit dans le corps humain | |
| EP3980052A4 (fr) | Conjugués d'insuline sensibles au glucose | |
| EP2428208A3 (fr) | Utilisation de substances réduisant la teneur cellulaire en glutathion pour la fabrication d'un médicament pour le traitement de maladies auto-immunes transmises par cellules T | |
| CN204428515U (zh) | 肝素帽与头皮针连接处保护固定装置 | |
| FR2944214B1 (fr) | Obtention et utilisation de principe actifs des calcaires | |
| Huang et al. | Continuous monitoring of glucose in subcutaneous tissue using microfabricated differential affinity sensors | |
| RU2012109006A (ru) | Инсулинсодержащий фармацевтический препарат для перорального применения | |
| KR20110041696A (ko) | 입술약 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20231201 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07K 14/62 20060101AFI20250217BHEP |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07K 14/62 20060101AFI20250507BHEP |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20250516 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20251202 |